nach oben

Erschienen in:

25.01.2022 | Brief Report

Recent molecular evolution of hepatitis B virus genotype F in Latin America

verfasst von: Jonas Michel Wolf, Thiago Kastell Mazeto, Vagner Reinaldo Zingalli Bueno Pereira, Daniel Simon, Vagner Ricardo Lunge

Erschienen in: Archives of Virology | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

The evolution of hepatitis B virus genotype F (HBV-F) in Latin America is not completely understood. The aim of this study was to evaluate the molecular evolution of HBV-F in Latin America by comparing 224 whole-genome sequences. Bayesian coalescent analysis was performed to estimate the time to the most recent common ancestor. Four main clades were found, dating from between 1245 and 1730. In addition, four subclades were identified, dating to between 1705 and 1801. The overall effective population size of HBV-F grew in the 18th century and showed an initial expansion outward from Venezuela to other countries from Latin America. Although HBV-F originated thousands of years ago, circulating strains of HBV-F appear to have spread in recent centuries, particularly in the 18^th and 19^th centuries. The new molecular data provide valuable information for characterizing the evolution of Native American HBV-F in recent centuries.

Nur mit Berechtigung zugänglich

WHO, World Health Organization (2020) Hepatitis B, 2020. http://www.who.int/mediacentre/factsheets/fs204/en/. Accessed March 2021

Tong S, Revill P (2016) Overview of hepatitis B viral replication and genetic variability. J Hepatol 64(1 Suppl):S4–S16. https://doi.org/10.1016/j.jhep.2016.01.027CrossRefPubMedPubMedCentral

Cagliani R, Forni D, Sironi M (2019) Mode and tempo of human hepatitis virus evolution. Comput Struct Biotechnol J 17:1384–1395. https://doi.org/10.1016/j.csbj.2019.09.007CrossRefPubMedPubMedCentral

McNaughton AL, D’Arienzo V, Ansari MA, Lumley SF, Littlejohn M, Revill P et al (2019) Insights from deep sequencing of the HBV genome-unique, tiny, and misunderstood. Gastroenterology 156(2):384–399. https://doi.org/10.1053/j.gastro.2018.07.058CrossRefPubMed

Paraskevis D, Magiorkinis G, Magiorkinis E, Ho SY, Belshaw R, Allain JP et al (2013) Dating the origin and dispersal of hepatitis B virus infection in humans and primates. Hepatology 57(3):908–916. https://doi.org/10.1002/hep.26079CrossRefPubMed

Mühlemann B, Jones TC, Damgaard PB, Allentoft ME, Shevnina I, Logvin A et al (2018) Ancient hepatitis B viruses from the Bronze Age to the Medieval period. Nature 557(7705):418–423. https://doi.org/10.1038/s41586-018-0097-zCrossRefPubMed

Kahila Bar-Gal G, Kim MJ, Klein A, Shin DH, Oh CS, Kim JW et al (2012) Tracing hepatitis B virus to the 16th century in a Korean mummy. Hepatology 56(5):1671–1680. https://doi.org/10.1002/hep.25852CrossRefPubMed

Patterson Ross Z, Klunk J, Fornaciari G, Giuffra V, Duchêne S, Duggan AT et al (2018) The paradox of HBV evolution as revealed from a 16th century mummy. PLoS Pathog 14(1):e1006750. https://doi.org/10.1371/journal.ppat.1006750CrossRefPubMedPubMedCentral

Zehender G, Ebranati E, Gabanelli E, Sorrentino C, Lo Presti A, Tanzi E et al (2014) Enigmatic origin of hepatitis B virus: an ancient travelling companion or a recent encounter? World J Gastroenterol 20(24):7622–7634. https://doi.org/10.3748/wjg.v20.i24.7622CrossRefPubMedPubMedCentral

10.

Mojsiejczuk L, Elizalde MM, López G, Figueredo D, Marquez N, Campos RH et al (2019) Molecular epidemiology of hepatitis B virus in Paraguay. Infect Genet Evol 71:91–97. https://doi.org/10.1016/j.meegid.2019.03.020CrossRefPubMed

11.

Pourkarim MR, Amini-Bavil-Olyaee S, Kurbanov F, Van Ranst M, Tacke F (2014) Molecular identification of hepatitis B virus genotypes/subgenotypes: revised classification hurdles and updated resolutions. World J Gastroenterol 20(23):7152–7168. https://doi.org/10.3748/wjg.v20.i23.7152CrossRefPubMedPubMedCentral

12.

Croagh CM, Desmond PV, Bell SJ (2015) Genotypes and viral variants in chronic hepatitis B: a review of epidemiology and clinical relevance. World J Hepatol 7(3):289–303. https://doi.org/10.4254/wjh.v7.i3.289CrossRefPubMedPubMedCentral

13.

Velkov S, Ott JJ, Protzer U, Michler T (2018) The global hepatitis B virus genotype distribution approximated from available genotyping data. Genes (Basel) 9(10):495. https://doi.org/10.3390/genes9100495CrossRef

14.

Roman S, Panduro A (2013) HBV endemicity in Mexico is associated with HBV genotypes H and G. World J Gastroenterol 19(33):5446–5453. https://doi.org/10.3748/wjg.v19.i33.5446CrossRefPubMedPubMedCentral

15.

Roman S, Jose-Abrego A, Fierro NA, Escobedo-Melendez G, Ojeda-Granados C, Martinez-Lopez E et al (2014) Hepatitis B virus infection in Latin America: a genomic medicine approach. World J Gastroenterol 20(23):7181–7196. https://doi.org/10.3748/wjg.v20.i23.7181CrossRefPubMedPubMedCentral

16.

Godoy BA, Pinho JRR, Fagundes NJR (2020) Hepatitis B virus: alternative phylogenetic hypotheses and its impact on molecular evolution inferences. Virus Res 276:197776. https://doi.org/10.1016/j.virusres.2019.197776CrossRefPubMed

17.

Martin DP, Murrell B, Golden M, Khoosal A, Muhire B (2015) RDP4: detection and analysis of recombination patterns in virus genomes. Virus Evol 1(1):vev003. https://doi.org/10.1093/ve/vev003CrossRefPubMedPubMedCentral

18.

Katoh K, Standley DM (2013) MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol 30(4):772–780. https://doi.org/10.1093/molbev/mst010CrossRefPubMedPubMedCentral

19.

Bouckaert R, Vaughan TG, Barido-Sottani J, Duchêne S, Fourment M, Gavryushkina A et al (2019) BEAST 2.5: an advanced software platform for Bayesian evolutionary analysis. PLoS Comput Biol 15(4):e1006650. https://doi.org/10.1371/journal.pcbi.1006650CrossRefPubMedPubMedCentral

20.

Kass RE, Raftery AE (1995) Bayes factors. J Am Stat Assoc 90(430):773–795CrossRef

21.

Rambaut A, Drummond AJ, Xie D, Baele G, Suchard MA (2018) Posterior summarization in Bayesian phylogenetics using tracer 1.7. Syst Biol 67(5):901–904. https://doi.org/10.1093/sysbio/syy032CrossRefPubMedPubMedCentral

22.

Lemey P, Rambaut A, Drummond AJ, Suchard MA (2009) Bayesian phylogeography finds its roots. PLoS Comput Biol 5(9):e1000520. https://doi.org/10.1371/journal.pcbi.1000520CrossRefPubMedPubMedCentral

23.

Bielejec F, Rambaut A, Suchard MA, Lemey P (2011) SPREAD: spatial phylogenetic reconstruction of evolutionary dynamics. Bioinformatics 27(20):2910–2912. https://doi.org/10.1093/bioinformatics/btr481CrossRefPubMedPubMedCentral

24.

Devesa M, Loureiro CL, Rivas Y, Monsalve F, Cardona N, Duarte MC et al (2008) Subgenotype diversity of hepatitis B virus American genotype F in Amerindians from Venezuela and the general population of Colombia. J Med Virol 80(1):20–26. https://doi.org/10.1002/jmv.21024CrossRefPubMed

25.

von Meltzer M, Vásquez S, Sun J et al (2008) A new clade of hepatitis B virus subgenotype F1 from Peru with unusual properties. Virus Genes 37(2):225–230. https://doi.org/10.1007/s11262-008-0261-xCrossRef

26.

Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO (2002) Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol 83(Pt 8):2059–2073. https://doi.org/10.1099/0022-1317-83-8-2059CrossRefPubMed

27.

González López Ledesma MM, Mojsiejczuk LN, Rodrigo B, Sevic I, Mammana L, Galdame O et al (2015) Hepatitis B virus genotype distribution and genotype-specific BCP/preCore substitutions in acute and chronic infections in Argentina. PLoS ONE 10(3):e0121436. https://doi.org/10.1371/journal.pone.0121436CrossRefPubMedPubMedCentral

28.

Rodrigo MB, Mojsiejczuk LN, Torres C, Sevic I, González López Ledesma MM, Perez PS et al (2016) Analysis of the molecular evolution of hepatitis B virus genotypes in symptomatic acute infections in Argentina. PLoS ONE 11(7):e0159509. https://doi.org/10.1371/journal.pone.0159509CrossRefPubMedPubMedCentral

29.

Livingston SE, Simonetti JP, McMahon BJ, Bulkow LR, Hurlburt KJ, Homan CE et al (2007) Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F. J Infect Dis 195(1):5–11. https://doi.org/10.1086/509894CrossRefPubMed

30.

Lampe E, Mello FCA, do Espírito-Santo MP, Oliveira CMC, Bertolini DA, Gonçales NSL et al (2017) Nationwide overview of the distribution of hepatitis B virus genotypes in Brazil: a 1000-sample multicentre study. J Gen Virol 98(6):1389–1398. https://doi.org/10.1099/jgv.0.000789CrossRefPubMedPubMedCentral

31.

Mello FC, Araujo OC, Lago BV, Motta-Castro AR, Moraes MT, Gomes SA et al (2013) Phylogeography and evolutionary history of hepatitis B virus genotype F in Brazil. Virol J 10:236. https://doi.org/10.1186/1743-422X-10-236CrossRefPubMedPubMedCentral

32.

Mojsiejczuk LN, Torres C, Sevic I, Badano I, Malan R, Flichman DM et al (2016) Molecular epidemiology of hepatitis B virus in Misiones, Argentina. Infect Genet Evol 44:34–42. https://doi.org/10.1016/j.meegid.2016.06.032CrossRefPubMed

33.

Torres C, Piñeiro y Leone FG, Pezzano SC, Mbayed VA, Campos RH (2011) New perspectives on the evolutionary history of hepatitis B virus genotype F. Mol Phylogenet Evol 59(1):114–122. https://doi.org/10.1016/j.ympev.2011.01.010CrossRefPubMed

34.

Mojsiejczuk L, Torres C, Flichman D, Campos RH (2020) Long-term evolution of hepatitis B virus genotype F: strong association between viral diversification and the prehistoric settlement of Central and South America. J Viral Hepat 27(6):620–630. https://doi.org/10.1111/jvh.13273CrossRefPubMed

35.

Gilbert C, Feschotte C (2010) Genomic fossils calibrate the long-term evolution of hepadnaviruses. PLoS Biol 8(9):e1000495. https://doi.org/10.1371/journal.pbio.1000495CrossRefPubMedPubMedCentral

36.

Simmonds P, Aiewsakun P, Katzourakis A (2019) Prisoners of war - host adaptation and its constraints on virus evolution. Nat Rev Microbiol 17(5):321–328. https://doi.org/10.1038/s41579-018-0120-2CrossRefPubMed

37.

Kocher A, Papac L, Barquera R, Key FM, Spyrou MA, Hübler R et al (2021) Ten millennia of hepatitis B virus evolution. Science 374(6564):182–188. https://doi.org/10.1126/science.abi5658CrossRefPubMed

38.

Alvarado Mora MV, Romano CM, Gomes-Gouvêa MS, Gutierrez MF, Botelho L, Carrilho FJ et al (2011) Molecular characterization of the hepatitis B virus genotypes in Colombia: a Bayesian inference on the genotype F. Infect Genet Evol 11(1):103–108. https://doi.org/10.1016/j.meegid.2010.10.003CrossRefPubMed

Titel: Recent molecular evolution of hepatitis B virus genotype F in Latin America
verfasst von: Jonas Michel Wolf
Thiago Kastell Mazeto
Vagner Reinaldo Zingalli Bueno Pereira
Daniel Simon
Vagner Ricardo Lunge
Publikationsdatum: 25.01.2022
Verlag: Springer Vienna
Erschienen in: Archives of Virology / Ausgabe 2/2022
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI: https://doi.org/10.1007/s00705-022-05376-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

05.06.2024 Hereditäres Angioödem Nachrichten

Medikamente zur Bedarfstherapie bei hereditärem Angioödem sind bisher nur als Injektionen und Infusionen verfügbar. Der Arzneistoff Sebetralstat kann oral verabreicht werden und liefert vielversprechende Daten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2022

Complete genome sequence of a new quadrivirus infecting a member of the genus Thelonectria

Emergence of two distinct variants of SARS-CoV-2 and an explosive second wave of COVID-19: the experience of a tertiary care hospital in Pune, India

Complete genome sequence of a distinct rosadnavirus isolated from Viola plants in China

Complete genome sequence of a new orthotospovirus associated with ringspot in Fatsia japonica

Genetic characteristics of spring viraemia of carp virus strains Kirov/08 and Orenburg/14